Hudson Bay Capital Management
NVAX icon

Hudson Bay Capital Management’s Novavax NVAX Stock Holding History

Hudson Bay Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,360
Closed -$92.5K – 1581
2026
Q1 		$92.5K Buy
+11,360
New +$103K ﹤0.01% 1190
2022
Q1 		– Sell
-5,000
Closed -$715K – 1277
2021
Q4 		$715K Buy
+5,000
New +$859K 0.01% 833

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Hudson Bay Capital Management's NVAX Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of Novavax (NVAX) in Q2 2026, closing a stake of 11,360 shares — an estimated $92.5K sold.

Hudson Bay Capital Management first reported a position in NVAX in Q4 2021 and held it in 2 quarters. The position peaked at $715K in Q4 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 11,360 Novavax shares in Q2 2026, an estimated $92.5K.
  • Hudson Bay Capital Management first reported a position in Novavax in Q4 2021 and held it in 2 quarters.
  • Hudson Bay Capital Management's Novavax position peaked at $715K in Q4 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.